arrow
A

Antonio Fernández-Serra

instituto de biomedicina de sevilla
H指数:19
被引数:1,261

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis

软组织肉瘤的预后和帕唑帕尼治疗反应的生物标志物:一项探索性分析

2026-07-310
PRE
Integration of an OS-Based Machine Learning Score (AS Score) and Immunoscore as Ancillary Tools for Predicting Immunotherapy Response in Sarcomas

基于操作系统学习的评分(AS评分)与免疫评分整合作为预测肉瘤免疫治疗反应的辅助工具

2025-08-200
PRE
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
2024-11-040
OAAI
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

REGISTRI: KIT/PDGFRA野生型转移性GIST的一线Regorafenib: 西班牙 (GEIS),意大利 (ISG) 和法国肉瘤组 (FSG) II期临床试验

2023-08-099
OAAI
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2-Metastatic Breast Cancer

CCNE1和PLK1介导HR /HER2-Metastatic乳腺癌对Palbociclib的耐药性

2023-02-0716
OAAI
REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
2021-09-015
OAAI
Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy
2014-07-01122
PREAI
MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study
2014-01-1326
PREAI
Molecular Diagnosis of Dermatofibrosarcoma Protuberans: A Comparison Between Reverse Transcriptase-Polymerase Chain Reaction and Fluorescence In Situ Hybridization Methodologies
2011-04-1162
PREAI
A polymorphism at the 3′-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole
2010-02-0971
OAAI